Clinical Trial

A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to estimate the difference in the time to onset of action between Staccato alprazolam and intravenous (iv) midazolam using changes in power in the combined spindle and β1 frequency bands in the qEEG (quantitative electroencephalogram).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-05; most recent amendment 2026-02-19.
Status change: Active, Not Recruiting → Completed 2026-02-19
Status change: Recruiting → Active, Not Recruiting 2026-01-15
Status change: Not Yet Recruiting → Recruiting 2025-07-10
Trial Details
NCT Number NCT07020988
Lead Sponsor UCB Biopharma SRL
Conditions Healthy Participants
Enrollment 55 participants
Start Date 2025-06-12
Primary Completion 2026-01-06 (estimated)
Study Completion 2026-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-20